Skip to main content
Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

152 wyświetleń
Pobierz
Farmaceutyczny

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Zaawansowana formuła farmaceutyczna do celowanego działania terapeutycznego.

Dawkowanie

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Moc

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Wielkość opakowania

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Postać

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Źródło

European Medicines Agency

Zobacz źródło

Profil bezpieczeństwa

Przeciwwskazania

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Skutki uboczne

Ulunar Breezhaler-H-C-3875-PSUV-0002: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Powiązane artykuły kliniczne